Scarica l'app Stockscreener
5.83
2.18%
-0.13
Engene Holdings Inc Borsa (ENGN) Ultime notizie
Engene Holdings Faces Regulatory Challenges and Business Risks Amid Clinical Trial Hurdles - TipRanks
enGene Holdings Inc. (ENGN) Upgraded to Strong Buy: Here's Why - MSN
enGene Holdings inks $100M share sale deal with Jefferies - Investing.com
EnGene : Material Agreement Form 8 K - Marketscreener.com
Form 424B5 enGene Holdings Inc. - StreetInsider.com
EnGene Holdings Inc. Reports Earnings Results for the Full Year Ended October 31, 2024 - Marketscreener.com
enGene Reports Full Year 2024 Financial Results and Provides a Business Update - BioSpace
(ENGN) Technical Pivots with Risk Controls - Stock Traders Daily
enGene Holdings Inc. (ENGN) reports earnings - Quartz
enGene (NASDAQ:ENGN) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
enGene Reports Promising 71% Response Rate in Bladder Cancer Trial, Strong $298M Cash Position - StockTitan
enGene Holdings: Compelling Early Data Bode Well For Their Near-Term Outlook (NASDAQ:ENGN) - Seeking Alpha
Here's Why enGene Holdings Inc. (ENGN) is Poised for a Turnaround After Losing -16.9% in 4 Weeks - MSN
(ENGN) Investment Analysis - Stock Traders Daily
Point72 Asset Management L.P. Has $4.38 Million Holdings in enGene Holdings Inc. (NASDAQ:ENGN) - MarketBeat
enGene’s (ENGN) Market Outperform Rating Reiterated at JMP Securities - Defense World
enGene's (ENGN) Market Outperform Rating Reiterated at JMP Securities - MarketBeat
enGene Holdings Inc. (NASDAQ:ENGN) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Critical Comparison: OKYO Pharma (NASDAQ:OKYO) versus enGene (NASDAQ:ENGN) - Defense World
Contrasting Immunovant (NASDAQ:IMVT) and enGene (NASDAQ:ENGN) - Defense World
Raymond James Initiates Coverage of enGene Holdings (ENGN) with Outperform Recommendation - MSN
enGene (NASDAQ:ENGN) Earns Outperform Rating from Analysts at Raymond James - MarketBeat
Recent uptick might appease enGene Holdings Inc. (NASDAQ:ENGN) institutional owners after losing 4.2% over the past year - Simply Wall St
enGene to Participate in Upcoming Investor Conferences - Vulcan Advocate
enGene Holdings to Present Cancer Treatment Updates at Major Healthcare Conferences - StockTitan
enGene (NASDAQ:ENGN) Coverage Initiated at JMP Securities - MarketBeat
JMP bullish on Engene stock as non-viral bladder cancer therapy gains traction By Investing.com - Investing.com South Africa
JMP bullish on Engene stock as non-viral bladder cancer therapy gains traction - Investing.com India
This TechnipFMC Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
(ENGN) Trading Advice - Stock Traders Daily
With 52% ownership of the shares, enGene Holdings Inc. (NASDAQ:ENGN) is heavily dominated by institutional owners - Yahoo Finance
Blue Owl Capital Holdings LP Increases Stake in enGene Holdings Inc - GuruFocus.com
enGene files $300M mixed securities shelf - TipRanks
enGene Holdings Inc. (NASDAQ:ENGN) Receives $33.67 Consensus PT from Brokerages - MarketBeat
How the (ENGN) price action is used to our Advantage - Stock Traders Daily
enGene to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference - BioSpace
enGene to Present Breakthrough Cancer Therapy at Guggenheim Healthcare Conference - StockTitan
Forbion growth opportunities fund acquires $4.99m in Engene Holdings shares - Investing.com Australia
Forbion growth opportunities fund acquires $4.99m in Engene Holdings shares By Investing.com - Investing.com South Africa
FY2024 EPS Estimates for enGene Boosted by Leerink Partnrs - MarketBeat
EnGene Announces $60 Million Private Placement Financing - Marketscreener.com
enGene Holdings Inc. (NASDAQ:ENGN) Sees Significant Growth in Short Interest - MarketBeat
enGene secures $60 million in private placement By Investing.com - Investing.com Canada
enGene Announces $60 Million Private Placement Financing - citybiz
Why enGene Holdings Stock Is Trading Higher - Benzinga
enGene secures $60 million in private placement - Investing.com
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):